Metraipolis › archive › dc_c2c8ebe37da9

FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities — Europe PMC PMID:41226813

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41226813
DOI
10.3390/ijms262110777
License (as archived)
solo-consultazione
Archived
2026-11-08T19:10:40.020Z
SHA-256 of the archived text
2d481f77649bad8c868ac97fe759ac95c2475203ab9410c790763d5b5ca3cba4
Stable URL of this page
https://metraipolis.com/documento/dc_c2c8ebe37da9

How to cite

FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities — Europe PMC PMID:41226813 — Europe PMC (en), https://europepmc.org/article/MED/41226813 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2c8ebe37da9 (Metraipolis archive dc_c2c8ebe37da9, sha256 2d481f77649bad8c868ac97fe759ac95c2475203ab9410c790763d5b5ca3cba4)
BibTeX
@misc{dcc2c8ebe37da9,
  title = {FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities — Europe PMC PMID:41226813},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41226813},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2c8ebe37da9; sha256 2d481f77649bad8c868ac97fe759ac95c2475203ab9410c790763d5b5ca3cba4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41226813. Agents can read the archived copy with the MCP tool read_document.